2018 - Fluorescently-Labeled Peptides – Choosing the Best Dye and Designing the Best Peptide
Topics/Call fo Papers
Fundamental Research, Life Sciences, Preclinical
Other CFPs
- Fluorescently-Labeled Peptides – Choosing the Best Dye and Designing the Best Peptide
- Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials
- Digital Health: Optimizing Clinical Trials with Patient-Centric Technology
- Make Better Pharmaceutical Portfolio Decisions – Using Failure Rates to Understand Portfolio Risks and Improve R&D Productivity
- How to Effectively Communicate with FDA Regulators
Last modified: 2018-09-27 00:46:51